Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Jul 27, 2026

Revenue (TTM)
$137.20B
+23.5% YoY
Gross margin
14.0%
EPS (latest q)
$10.31
vs $10.20 est · beat
52-wk position
91.9%
-4.9% vs 52w high · +3.8% 1mo

Price (last ~year)

Humana Inc. reported $39.65 billion in revenue for the quarter ending March 31, 2026, a 23.5% year-over-year increase, while annual earnings declined 4.6%. The stock is trading at $389.32, above the $347.96 analyst target, following a 69.9% gain over the last three months. Institutional activity remains mixed, marked by recent shifts in major shareholdings.

Valuation

Market cap
$47.74B
P/E
41.51
PEG
2.205
P/B
2.516
P/S
0.343
Beta
0.717
Analyst target
$347.96

Quality & returns

Gross margin
14.0%
Operating margin
4.7%
Profit margin
0.8%
ROE
6.3%
ROA
3.6%

Price movement

Last
$389.32
1-month
+3.8%
3-month
+69.9%
RSI (14)
48
vs SMA200
+48.8%
52-wk position
91.9% -4.9% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M
2025-06-30$32.39B$722.0M$545.0M$1.09B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots